specific demographics and procedures performed, workers' compensation status, persistent structural abnormalities, labral deficiency, chondral damage, capsular instability, and preoperative osteoarthritis. 4, 7, 30, 32, 35 Preoperative physical therapy (PT) and diagnostic intraarticular (IA) injections have been identified as potential prognostic indicators. Insurers frequently require preoperative PT for approval, suggesting a perceived importance for surgical indications, despite a paucity of supporting data. In a small, randomized controlled pilot study, patients diagnosed with FAI were randomized to 7 weeks of supervised exercise with manual therapy versus activity modification counseling and a home exercise program. 45 Both cohorts reported significant improvements in pain and range of motion, suggesting that some hip abnormalities may be amenable to conservative management. 45 However, this study concluded that while PT may improve short-term pain and function, it does not address the underlying osseous morphology. This was supported by larger randomized clinical trial data suggesting that while PT can improve symptoms, hip arthroscopic surgery had more significant, clinically important improvements. 15 Imaging-guided IA injections may also assist surgical decision making, including the evaluation of IA versus extra-articular hip pain sources. In fact, some insurance guidelines also require these injections for approval, with guidelines based on data demonstrating that a negative response to an IA injection may be associated with a poor surgical outcome. 3 Thus, over 80% of patients undergoing hip arthroscopic surgery report receiving IA injections before surgery. 21 However, studies have contradicted these findings, 22 and minimal data exist correlating preoperative IA injections to increased postoperative revision or care.
The goals of this study were to identify demographic variables, comorbidities, and preoperative evaluation modalities (PT, IA injection) that may be associated with early revision hip arthroscopic surgery, conversion to THA, other surgical procedures, extended medical care, and prolonged pain medication usage after index hip arthroscopic surgery.
METHODS
With institutional review board (#98713) approval, Utah's All Payer Claims Database (APCD) was queried to include a 3-year period between January 1, 2013, and December 31, 2015. Patients were identified using Current Procedural Terminology (CPT) codes and included if they were 14 years old, continuously insured, and had claims information at 6 months preoperatively and 12 months postoperatively. Utah's APCD is a state-mandated registry that contains claims data from all private and public payers (Medicare Advantage and Medicaid), representing 2.4 million persons and 80% of Utah's population beginning in the year 2013. 41, 43 The APCD provided 3-year longitudinal data, affording the ability to correlate large-volume preoperative factors with postoperative management in a fashion not available with other hip arthroscopic surgery studies using a large database. 19 With the date of surgery as the index date, common diagnostic indicators and conservative interventions were collected at 6 months preoperatively and 12 months postoperatively using CPT codes (Appendix Table A1 ). Revision hip arthroscopic surgery, conversion to THA, lumbosacral surgery, and abdominal surgery were included to capture procedures that could indicate a failure of the index surgery to satisfactorily relieve symptoms. The concern was that patients who underwent abdominal or lumbosacral surgery shortly after the index arthroscopic surgery were not properly diagnosed before the initial arthroscopic procedure was performed. Preoperative and postoperative PT, IA hip injections, epidural/facet lumbosacral injections, and pain medications (opioids, nonsteroidal antiinflammatory drugs [NSAIDs] , and skeletal muscle relaxants) were also identified and analyzed using CPT codes, National Drug Code data, and medication names.
Baseline demographic data, insurance type, urban or rural regional designation indicating where the patient lived at the time of surgery, and comorbidities were identified. Age was measured in years at index surgery, and age squared was included in the regression models because of a significant nonlinear trend in this variable's effect on postoperative interventions. Sex was dichotomized as male or female. Comorbidities were binary and identified based on International Classification of Diseases, Ninth Revision (ICD-9), codes (Appendix Table A1 ). Insurance type was categorized as commercial/private or government funded (Medicaid or Medicare). Patients with dual Medicaid/Medicare enrollment (n ¼ 11) were excluded from the analysis.
Descriptive statistics, including means, standard deviations, frequencies, and percentages, were used to describe the sample. To identify factors that were associated with the outcomes, multivariate logistic regression was used, and odds ratios (ORs) and P values were reported in the regression table. The significance level was set at .05 for all analyses using Stata statistical software (v 14; StataCorp).
RESULTS
The analyzed sample included 3443 patients who underwent hip arthroscopic surgery between January 1, 2013, and December 31, 2015. Patients were excluded from the final analysis for the following reasons: lacked 1-year follow-up data after index surgery (n ¼ 1030), were not continuously enrolled in insurance during the study period (n ¼ 1028), were missing demographic data (n ¼ 68), or were younger than 14 years at the time of index surgery (n ¼ 34).
A total of 1283 patients who underwent primary hip arthroscopic surgery, 57.6% (n ¼ 739) female and 42.4% (n ¼ 544) male, were included in the final analysis (Table 1) . Patients were more likely to have private insurance than Medicare or Medicaid (89.1% vs 10.9%, respectively) and live in urban rather than rural regions (88.5% vs 11.5%, respectively). Common comorbidities, identified by ICD-9 codes, included depression (23.3%), smoking (11.9%), obesity (11.6%), and diabetes (10.0%) ( Table 2) .
Of the patients included, 7.8% underwent revision arthroscopic surgery, and 2.1% converted to THA within 1 year of hip arthroscopic surgery. Additionally, 2.4% and 1.2% of patients underwent lumbosacral surgery and abdominal surgery, respectively, within 1 year of hip arthroscopic surgery (Table 3) .
Injections were prevalent in the preoperative and postoperative settings (46.7% and 34.3%, respectively). IA hip injections were most common, with 45.1% and 29.5% of patients receiving at least 1 injection preoperatively and postoperatively, respectively. Lumbosacral epidural or facet joint injections increased from 1.6% preoperatively to 4.8% postoperatively ( Preoperative opioid use was the only medication found to be associated with increased odds of revision arthroscopic surgery (OR, 1.64; P ¼ .05), THA (OR, 2.70; P ¼ .03), and lumbosacral surgery (OR, 2.44; P ¼ .04). The utilization of preoperative conservative treatments such as PT and injections was not significant (Table 5) .
DISCUSSION
Hip arthroscopic surgical indications are multifactorial and rely on a comprehensive patient evaluation. This study demonstrated that (1) there were preoperative patient variables, including age and sex, that affected prognosis; (2) preoperative interventions, including PT and IA injections, did not influence revision or conversion rates; (3) patients with obesity, diabetes, and opioid use were associated with higher revision and conversion rates; and (4) a subset of patients potentially required additional surgical interventions based on underlying comorbidities. A prior large, population-based study documented an increased risk of conversion to THA within 2 years of arthroscopic surgery among patients with osteoarthritis, obesity, or treatment in a low-volume hip arthroscopic surgery institution. 35 Age and sex have also been implicated, with increased conversion to THA after hip 14 Age and articular cartilage health appear to have a critical role; among 8.7% of patients who converted to THA within 24 months, 17.1% were between 50 and 59 years old, and 16.5% were older than 60 years. 36 Over 99% of these patients had preoperative osteoarthritis, regardless of age. 36 Conversely, improved outcomes after hip arthroscopic surgery in older populations, despite an elevated conversion rate, 10 have highlighted this controversy.
In our cohort, age and sex significantly correlated with postoperative revision hip arthroscopic surgery and conversion to THA. The age of 60 years was the threshold above which the risk for revision hip arthroscopic surgery significantly increased, in contrast to published data that suggested a 40-year age threshold. 19, 34 We believe that this increased age threshold reflects an improved understanding of the importance of articular cartilage health in hip arthroscopic surgery decision making. On the other hand, conversion to THA displayed an age-based linear trend, with patients being more at risk for eventual conversion as they increased in age. This likely indicates the progressive nature of osteoarthritis that may ultimately influence the failure of the index arthroscopic procedure. 9, 18, 19, 35, 36 These data suggest a correlation of articular cartilage health to the revision rate. Prior studies 2,5,6,31 have suggested this preliminary relationship, but further research is necessary. Future prognostic studies should consider including magnetic resonance imaging or other specific measures of articular cartilage health.
Interestingly, male sex demonstrated higher rates of arthroscopic revision and conversion to THA (OR, 1.59 and 2.25, respectively). This contrasts with previous data 33, 36 documenting worse outcomes in female patients but no sex difference in patients younger than 45 years. 45 It is possible that male and female patients differ in their desire to undergo surgery, perceived acceptable level of functional impairment, and risk aversion. Women undergoing orthopaedic procedures have documented worse preoperative functional status compared with men, suggesting an advanced disease at the time of the index procedure. 16 Male patients after total knee arthroplasty reported decreased 36-Item Short Form Health Survey physical scores, while female patients had lower general health scores, thus suggesting that physical and mental health might be more interrelated for female patients. 44 Male patients also had greater postoperative improvement in social function, physical role function, pain scores, energy, and mental health.
12,27 Thus, it may be possible that male patients inherently seek and benefit from earlier surgical interventions and that female patients delay before pursuing surgery and may benefit less.
Diabetic patients undergoing hip arthroscopic surgery had a greater risk of subsequent lumbosacral surgery, and obese patients were more likely to have conversion to THA. Patients in these categories could benefit from counseling to optimize glucose control and weight loss before surgery, which may affect this revision rate. A 1.2% subset of patients underwent additional abdominal surgery, suggesting that multiple causes of hip pain exist and are not always identified before hip arthroscopic surgery. Finally, preoperative opioid use was significantly associated with revision arthroscopic surgery, conversion to THA, and lumbosacral surgery. Implementing alternative pain management strategies before and after hip arthroscopic surgery may reduce these postoperative revision rates.
Our data revealed no relationship between preoperative PT or IA injections and revision surgery or extended postoperative medical care. These data may suggest that some patients who undergo hip arthroscopic surgery may have an anatomic issue that is not correctable via preoperative PT. While it is likely that patients who responded to PT and did not undergo surgery were not included in our analysis, we believe that this should make the 32.0% of the patients who had preoperative PT a more selective population that theoretically may have a more optimal postoperative course. However, this was not found. Rather, the lack of significant differences in the aforementioned variables between patients who did or did not undergo preoperative PT should represent a worst-case scenario in which patients who had no preoperative PT were compared with those who did. The lack of difference suggests that patients with underlying mechanical pathomorphology may not respond to preoperative PT and that surgical indications should be based on other factors such as history, physical examination results, and radiographic findings, among others.
A study by Mansell et al 24 in 2018 found no significant difference between patients with FAI allocated to surgery versus rehabilitation, suggesting a primary role for PT in FAI. However, their study had an unusually high rate of crossover, an underpowered "as-treated" analysis, and very small improvements in patient-reported outcomes after surgery inconsistent with previous literature, 13 making the results difficult to interpret. Our data suggest that while PT plays a role in preoperative management, it does not ultimately significantly influence outcomes in terms of the need for revision surgery or other intervention. Given this, it does not seem that PT has a primary role in managing this particular abnormality, and it is worth considering if PT should be focused during postoperative care. This could potentially reduce costs overall, avoid limiting PT visits prematurely secondary to insurance restrictions, and solve the issue of PT failure influencing surgical indications. We suggest that PT may be best allocated to postoperative recovery and advocate for re-evaluation of insurance coverage criteria that mandate preoperative PT.
Interestingly, preoperative IA injections did not significantly correlate with increased revision surgery or extended postoperative interventions. While it is possible that patients who received a negative response to IA injections did not undergo surgery and thus were not included, this would increase the difference between the IA and non-IA injection cohorts, but no significant correlation existed. Our data support previous data that documented a limited prognostic benefit to the ubiquitous use of IA injections. 22 Nevertheless, the selective use of preoperative diagnostic IA injections may remain important for patients with increased complexity and multiple pain generators, in
The Orthopaedic Journal of Sports Medicine Risk Factors for Early Failure of Hip Arthroscopic Surgery 5 which a negative response to injections helps steer them from surgical interventions. The type of insurance was not significantly related to the need for revision hip arthroscopic surgery, THA, or lumbosacral surgery. Those with private insurance had an OR of 1.75 to undergo revision hip arthroscopic surgery (P ¼ .24), an OR of 1.38 to undergo THA (P ¼ .65), and an OR of 1.17 to undergo lumbosacral surgery (P ¼ .76). The trend appeared to be that those with private insurance were more likely to eventually need an additional procedure, although this was not significant. There were significantly decreased odds of undergoing abdominal surgery with private insurance (OR, 0.09; P < .001). The reason for this relationship was not abundantly clear, although it is reasonable to surmise that those with public insurance have a wider range of health disparities and medical concerns and ultimately experience different postoperative hospital courses, including an increased length of stay. 11 The relationship between public insurance and overall outcome is a complex topic and one that we did not seek to address in this study. Further investigation is clearly warranted regarding whether type of insurance serves as an overall indicator of patient health status as well as the role that type of insurance plays in determining clinical outcomes.
Limitations
Our data are affected by the inherent limitations that exist with a large database analysis. 28 The APCD relies on the accuracy of CPT and ICD-9 coding by surgeons and billers in Utah, and coding errors may affect the accuracy of these data. Patients captured included those who were continuously insured and had claims information at 6 months before and 12 months after surgery. Following data beyond the 1-year mark postoperatively could provide even more insight into revision surgery and treatment utilization. However, our ability to capture data at 6 months preoperatively and 12 months postoperatively should include the majority of early failures and complications.
Furthermore, we restricted our data search to patients aged 14 years, and thus, these data may not be applicable to very young populations. However, hip arthroscopic surgery is rarely indicated in skeletally immature populations, and thus, we believe that our data remain generalizable. Uninsured patients and patients with fee-for-service Medicare may represent a unique subset with different outcomes that we were unable to capture within the scope of our research. However, our ability to include commercial insurance payers, Medicaid, and Medicare Advantage should provide reasonable generalizability of these results to the majority of patients. It is possible that patients may have moved to Utah State immediately before or shortly after their index surgery, which may affect data accuracy. However, the APCD is not restricted by state but rather by insurance carrier. Given this, procedures that were performed in a different state but collected by the same insurance provider would be included, thereby limiting the frequency of these events.
In addition, we were unable to evaluate individual cases, including the specific details of imaging and arthroscopic surgery. Thus, subtleties such as dysplasia and early osteoarthritis seen at the time of arthroscopic surgery could not be collected. Subtleties among variables such as degree of obesity and severity of diabetes could also not be determined because of the binary nature of ICD-9 coding. Additionally, our 1-year follow-up inevitably did not include failures and revisions that occur later than this time period. Our database does not evaluate the surgical volume of providers, as this was not available. Finally, we did not have data on whether the "index" procedure may have been a revision of a surgical procedure performed before the data set query. Despite the aforementioned limitations, the large sample size and 3-year data capture provide the unique ability to riskstratify many patient variables. Finally, it is not possible to identify laterality of the surgical procedure (both index and revision) utilizing CPT and ICD-9/10 codes. This is a limitation in that we did not know with certainty that the revision procedure was performed on the ipsilateral limb. Our assumption, given the practices of our institution, is that a revision procedure on the ipsilateral side is more likely than an additional index procedure on the contralateral side.
CONCLUSION
A relationship analysis among patient demographic and postoperative variables allows the development of a preoperative surgical algorithm to optimize outcomes and guide patient expectations. Patient selection for hip arthroscopic surgery should consider other causes of hip pain, including intra-abdominal abnormalities and lumbosacral spine disease. Patients aged 40 to 60 years and especially those over 60 years may benefit from advanced preoperative imaging to evaluate articular cartilage health. Our findings encourage a comprehensive preoperative assessment including HbA1c and body mass index, and particular focus should be placed on opioid usage identification and nonopioid pain strategies. The identification of factors that may increase future revision will hopefully improve patient outcomes and reduce revisions and extended postoperative medical care. 
APPENDIX

